Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features

被引:19
|
作者
Parrens, M
Belaud-Rotureau, MA
Fitoussi, O
Carerre, N
Bouabdallah, K
Marit, G
Dubus, P
de Mascarel, A
Merlio, JP
机构
[1] Univ Bordeaux 2, Dept Pathol & Tumour Biol, Equipe 2406, F-33076 Bordeaux, France
[2] CHu Bordeaux, Dept Pathol & Tumour Biol, Bordeaux, France
[3] Hop Haut Leveque, Dept Haematol, Pessac, France
关键词
blastoid variant; CDK4; cyclin D1; FISH; Ki67; mantle-cell lymphoma;
D O I
10.1111/j.1365-2559.2005.02323.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: The recognition of blastoid variant (BV) of mantle cell lymphoma (MCL) is based on morphological criteria. Our aim was to analyse 18 MCL cases including four BV-MCL for their clinicopathological features, proliferation index, cyclin D1 and CDK4 expression and interphase fluorescence in-situ hybridization (FISH) pattern. Methods and results: BV-MCL versus common MCL was characterized by a shorter overall duration of response after first-line therapy (11 months versus 28 months) and shorter overall survival (20 months versus 42 months). Interphase FISH showed a t(11;14) fusion pattern in all MCL tested cases. However, the four blastoid cases were characterized by extra copies of CCND1 signals. Using additional probes of chromosomes 11, 18, 21, these signals were shown to be the result of hypotetraploidy and not of a specific amplification of the normal or the translocated CCND1 allele. Moreover, the BV-MCL cases were characterized by a combined high percentage of cells expressing cyclin D1 and/or CDK4 with a proliferation (MIB-1-Ki67) index above 50%. Such features allowed the recognition of areas of large cell transformation in the case of secondary BV-MCL. Conclusions: Since distinction between BV and common MCL is of clinical relevance, our data underline the need to add phenotypic and cytogenetic criteria to cytomorphology for a better recognition of BV-MCL.
引用
收藏
页码:353 / 362
页数:10
相关论文
共 50 条
  • [21] Differential expression of CKS-1B in typical and blastoid variants of mantle cell lymphoma
    Akyurek, Nalan
    Drakos, Elias
    Giaslakiotis, Konstantinos
    Knoblock, Ronald J.
    Abruzzo, Lynne V.
    Ning, Yi
    Rassidakis, Georgios Z.
    Medeiros, L. Jeffrey
    HUMAN PATHOLOGY, 2010, 41 (10) : 1448 - 1455
  • [22] Blastoid variant of mantle cell lymphoma in palatine tonsil
    Valente, Vitor Bonetti
    de Castro, Tamara Fernandes
    Takamiya, Aline Satie
    Callestini, Renata
    Xavier-Junior, Jose Candido Caldeira
    Cortopassi, Gabriel Macedo
    Neto, Sebastiao Conrado
    Collado, Francisco Urbano
    Biasoli, Eder Ricardo
    Miyahara, Glauco Issamu
    Bernabe, Daniel Galera
    ORAL ONCOLOGY, 2021, 122
  • [23] Composite Blastoid Variant of Mantle Cell Lymphoma and Classical Hodgkin Lymphoma
    Murray, Ciara
    Quinn, Fiona
    Illyes, Gyorgy
    Walker, Jan
    Castriciano, Giussepa
    O'Sullivan, Paul
    Grant, Cliona
    Vandenberghe, Elisabeth
    Bird, Brian
    Flavin, Richard
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2017, 25 (03) : 281 - 286
  • [24] 3 HISTOLOGICAL VARIANTS OF MANTLE CELL LYMPHOMA (MCL) EXHIBIT STRIKING HETEROGENEITY IN CLINICAL BEHAVIOR AND BIOLOGICAL FEATURES
    MAJLIS, A
    PUGH, W
    RODRIGUEZ, MA
    CABANILLAS, F
    BLOOD, 1993, 82 (10) : A388 - A388
  • [25] Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience
    Bhatt, Vijaya R.
    Loberiza, Fausto R., Jr.
    Smith, Lynette M.
    Armitage, James O.
    Greiner, Timothy C.
    Bast, Martin
    Lunning, Matthew A.
    Bierman, Philip J.
    Vose, Julie M.
    Bociek, R. Gregory
    LEUKEMIA & LYMPHOMA, 2016, 57 (06) : 1327 - 1334
  • [26] Cytogenetic findings in sixteen cases of blastoid mantle cell lymphoma
    Sen, F
    Abruzzo, LV
    Lu, D
    Hayes, K
    Glassman, A
    Medeiros, LJ
    LABORATORY INVESTIGATION, 2002, 82 (01) : 263A - 263A
  • [27] Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma
    Gerson, James N.
    Handorf, Elizabeth
    Villa, Diego
    Gerrie, Alina S.
    Chapani, Parv
    Li, Shaoying
    Medeiros, Jeffrey
    Wang, Michael
    Cohen, Jonathon B.
    Churnetski, Michael
    Hill, Brian T.
    Sawalha, Yazeed
    Hernandez-Ilizaliturri, Francisco J.
    Kothari, Shalin
    Vose, Julie M.
    Bast, Martin
    Fenske, Timothy
    Gari, Swapna Narayana Rao
    Maddocks, Kami J.
    Bond, David
    Bachanova, Veronika
    Kolla, Bhaskar
    Chavez, Julio
    Shah, Bijal
    Lansigan, Frederick
    Burns, Timothy
    Donovan, Alexandra M.
    Wagner-Johnston, Nina
    Messmer, Marcus
    Mehta, Amitkumar
    Anderson, Jennifer K.
    Reddy, Nishitha
    Kovach, Alexandra E.
    Landsburg, Daniel J.
    Glenn, Martha
    Inwards, David J.
    Ristow, Kay
    Karmali, Reem
    Kaplan, Jason B.
    Caimi, Paolo F.
    Rajguru, Saurabh
    Evens, Andrew
    Klein, Andreas
    Umyarova, Elvira
    Pulluri, Bhargavi
    Amengua, Jennifer E.
    Lue, Jennifer K.
    Diefenbach, Catherine
    Fisher, Richard I.
    Barta, Stefan K.
    BLOOD ADVANCES, 2023, 7 (24) : 7393 - 7401
  • [28] Blastoid mantle cell lymphoma in a patient with chronic myeloproliferative neoplasia
    Soares, Thamiris Silva
    Soares, Joao Savio Silva
    David, Gabriela Lemes
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (01) : 113 - 115
  • [29] Blastoid Mantle Cell Lymphoma With Cutaneous Involvement and Aberrant Immunophenotype
    Phelps, Amanda
    Elaba, Zendee
    Murphy, Michael J.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2014, 36 (06) : 526 - 527
  • [30] Blastoid Mantle Cell Lymphoma Presenting as an Isolated Cecal Mass
    Bathobakae, Lefika
    Lopez Cuello, Jorge L.
    Bashir, Rammy
    Farhan, Heba
    Atogwe, Irhoboudu D.
    Cavanagh, Yana
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2025, 13